GGrantIndex
Sort

59,101 grants matching hypertension

Cardioprotective Effect of Growth Hormone Releasing Hormone

$669,004
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2019 · HL

Cardioprotective Effect of Growth Hormone Releasing Hormone

$669,004
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2017 · HL

Frequent Hemodialysis Network - West Coast Consortium

$669,000
Glenn Matthew Chertow · Stanford University · U01 · FY2009 · DK

Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program

$668,977
Dike Bevis Ojji · University Of Abuja · UH3 · FY2025 · HL

CV Disease in Adolescents with Type 2 Diabetes

$668,954
Thomas R Kimball · Cincinnati Childrens Hosp Med Ctr · R01 · FY2007 · HL

Early joint cranial and brain development from fetal and pediatric imaging

$668,942
Natasha Lepore · Children'S Hospital Of Los Angeles · R01 · FY2025 · DE

E-TREAT: Evaluation of Telemedicine for diabetes care in Latinos

$668,936
Miguel Marino · Oregon Health & Science University · R01 · FY2023 · DK

Genetics of In Vivo and In Vitro Endothelial Function in African Americans

$668,882
Michael David Brown · Temple Univ Of The Commonwealth · R01 · FY2007 · HL

The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity

$668,841
Xiao-Feng Yang · Temple Univ Of The Commonwealth · R01 · FY2019 · HL

Epidemiology: Oxidative Stress and Early Atherosclerosis

$668,827
David R Jacobs · University Of Minnesota · R01 · FY2006 · HL

Functional Impact of Col18a1/Endostatin Variants in PAH

$668,824
Rachel L Damico · Johns Hopkins University · R01 · FY2017 · HL

Multi-Component Behavioral Intervention for Complex Patients with CVD Risk

$668,818
Richard W Grant · Kaiser Foundation Research Institute · R01 · FY2018 · HL

Stress Phenotypes and Preterm Birth: Immune and Energetic Cellular Dysregulation and the Preventive Effect of Social Support

$668,806
Catherine E Monk · Columbia University Health Sciences · R01 · FY2023 · MD

THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES

$668,804
John P Forman · Brigham And Women'S Hospital · R01 · FY2020 · HL

THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES

$668,804
John P Forman · Brigham And Women'S Hospital · R01 · FY2019 · HL

Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes

$668,794
Aniket A Kawatkar · Kaiser Foundation Research Institute · R01 · FY2023 · HL

The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases

$668,781
Arya Mani · Yale University · R01 · FY2024 · DK

Mechanisms linking hot flashes to cardiovascular risk

$668,771
Rebecca C Thurston · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · HL

Examining COVID-19 in Down Syndrome Patients Using Human iPSC-Derived Organoids

$668,755
Joseph C Wu · Stanford University · R01 · FY2021 · HL

Novel pharmacotherapy strategies for obesity in schizophrenia

$668,723
Lars Fredrik Jarskog · Univ Of North Carolina Chapel Hill · R01 · FY2018 · DK

Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus

$668,658
Matthew A Allison · University Of California, San Diego · R01 · FY2022 · HL

THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES

$668,655
John P Forman · Brigham And Women'S Hospital · R01 · FY2018 · HL

Animal Models for Studying the Genetics of Hypertension

$668,616
University Of North Carolina Chapel Hill · R01 · FY2002 · HL

Renal endothelin receptor-specific function in angiotensin ll-dependent hypertens

$668,572
David M Pollock · Augusta University · P01 · FY2013 · HL

Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis and Care Cascade for HIV-infected Individuals (SAIA-HTN)

$668,567
Sarah Odell Gimbel · University Of Washington · R01 · FY2021 · HL